[Event Report] The Project for Considering the Future of Precision Medicine with Industry, Government, Academia, and Civil Society – The Policy Dialogue Event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” (October 11, 2023)
date : 11/6/2023
Tags: NCDs, Precision Cancer Medicine
Health and Global Policy Institute (HGPI) held the policy dialogue event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” on October 11, 2023.
Personalized cancer medicine, in which treatment is tailored to individuals in accordance with the genetic mutations and other characteristics of their cancer, is expected to play an important role in the future.
We believe that among personalized cancer care, genomic cancer medicine can be delivered more broadly to the public as several years have now passed since Comprehensive Genomic Profiling (CGP; or cancer gene panel tests) was granted health insurance coverage in 2019, and those serving in clinical settings are starting to gain experience with this form of medicine.
Moreover, the “Bill on the Comprehensive and Systematic Promotion of Measures to Ensure the Public Can Access High-Quality, Suitable Genomic Medicine with Peace of Mind” (a bill to promote genomic cancer medicine) was passed in June 2023.
However, there are policy challenges with respect to delivering genomic cancer medicine may be not only issues that are universally faced by Japanese healthcare, but also many issues that are unique to cancer genome medicine.
HGPI held, Policy Dialogue Event “Challenges and Prospects for the Improving Patient Access to Genomic Cancer Medicine” on October 11, 2023 to deepen discussions based on Policy Recommendations “Improving Patient Access to Genomic Cancer Medicine policy proposal” (August 10, 2023) and to serve as a bridge for implementation into society.
[Event Overview]
- Date & Time: Wednesday, October 23, 2023; form 13:30 to 15:00 JST
- Format: Hybrid (In-Person and Online (Zoom Webinars))
- Venue: Zenkoku Choson Kaikan
- Sponsors (Japanese Order):
MSD K.K.
National Graduate Institute for Policy Studies (GRIPS) Global Health Innovation Policy Program (GHIPP)
Chugai Pharmaceutical Co., Ltd.
Bayer Yakuhin, Ltd.
Janssen Pharmaceutical K.K.
[Program] (Titles omitted, Japanese order)
13:30-13:35 | Opening Remarks and Introduction |
Haruka Sakamoto (Senior Manager, HGPI) | |
13:35-14:05 | Panel Discussion (1) “Measures needed to make Genomic Cancer medicine more common” |
Shinsuke Amano (Executive Director, Japan Federation of Cancer Patient Groups/Executive Director, Group Nexus Japan) Moderator: Osamu Takemoto (Program Specialist, HGPI) |
|
14:05-14:15 | Free Discussion |
14:15-14:45 | Panel Discussion (2) “Measures to improve patient access to genomic cancer medicine in rural area” |
Naomi Sakurai (President, Cancer Solutions Co., Ltd) Moderator: Shu Suzuki (Senior Associate, HGPI) |
|
|
|
14:45-14:55 | Free Discussion |
14:55-15:00 | Closing Remarks |
Kiyoshi Kurokawa (Chairman, HGPI) |
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Reserch Report] Antimicrobial Resistance (AMR) Measures in Sweden (November 21, 2024)
- [Policy Recommendations] The Women’s Health Promotion Project “Policy proposal for Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (July 31, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
Featured Posts
-
2024-11-25
[Registration Open] (Webinar) The 130th HGPI Seminar “Marking a Decade of the Act on Medical Care for Patients With Intractable Diseases: Connecting Intractable Diseases and Society From the Perspective of a Media Professional and Family Member” (January 28, 2025)
-
2024-11-29
[Registration Open] (Webinar) The 129th HGPI Seminar “The Connection Between Planetary Environment and Human Health as Seen Through the JECS and Future Expectations” (December 23, 2024)
-
2024-12-09
[Policy Recommendations] Integrating Climate and Health for a Sustainable Society: Incorporating a Planetary Health Perspective into Nationally Determined Contributions (NDCs)(December 9, 2024)
-
2024-12-12
[HGPI Policy Column] (No. 51) From the Planetary Health Project “Part 11: Efforts Toward Achieving Carbon Neutrality in Japan’s Pharmaceutical Industry”
-
2024-12-18
[Policy Recommendations] Policy Recommendations on Strengthening CKD Strategies for Workers: The Importance of Providing Early Detection, Intervention, and Support Through Screenings and Medical Visits (October 28, 2024)